VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹156 Cr | ₹86 Cr | ₹37 Cr | ₹37 Cr | ₹41 Cr |
What is the latest Cash Flow from Operating Activities ratio of VENUS REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹156 Cr |
| Mar2025 | ₹86 Cr |
| Mar2024 | ₹37 Cr |
| Mar2023 | ₹37 Cr |
| Mar2022 | ₹41 Cr |
How is Cash Flow from Operating Activities of VENUS REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹156 Cr | 80.20 | |
| Mar2025 | ₹86 Cr | 131.84 | |
| Mar2024 | ₹37 Cr | 1.80 | |
| Mar2023 | ₹37 Cr | -10.89 | |
| Mar2022 | ₹41 Cr | - | |
Compare Cash Flow from Operating Activities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,714.2 Cr | -8.4% | -21.6% | 194.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -8.4% |
-21.6% |
194.9% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses